Business
New Brazil data shows disappointing 50.4% efficacy for China’s CoronaVac vaccine – Sydney Morning Herald
It’s the news Indonesian President Joko Widodo probably didn’t want to hear.
“We have a good vaccine. Not the best vaccine in the world. Not the ideal vaccine,” said microbiologist Natalia Pasternak, criticising Butantan’s triumphant tone.
Last week, the Brazilian researchers had celebrated results showing 78 per cent efficacy against “mild-to-severe” COVID-19 cases, a rate they later described as “clinical efficacy”.
They said nothing at the time about another group of “very mild” infections among those who received the vaccine that did not require clinical assistance.
…
-
Business18 hours ago3 high-conviction ASX 200 stocks to buy and hold
-
Business22 hours agoWhat’s the average superannuation balance at retirement age? (That’s 67)
-
General10 hours agoGrattan Institute pitches blueprint to ‘save’ NDIS as foundational supports rollout stalls
-
Noosa News24 hours agoDr Sally Shrapnel became one of Australia’s leading scientists in her area after taking a quantum leap